Increased risks of psychiatric disorders in patients with primary Sjögren’s syndrome—a secondary cohort analysis of nationwide, population-based health claim data

Abstract

Introduction/objectives

Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease. The aim of this study was to investigate the risk of five common psychiatrist-diagnosed disorders in patients with pSS.

Method

Using Taiwan’s National Health Insurance Research Database, 688 patients with newly diagnosed pSS between 2000 and 2012 were identified. Two comparison cohorts were assembled, namely, 3440 patients without pSS and 1302 newly diagnosed patients with rheumatoid arthritis. The incidences of depressive disorder, anxiety disorder, bipolar disorder, sleep disorder, and schizophrenia between the pSS cohort and the comparison cohorts were compared using Poisson regression models.

Results

Patients with pSS exhibited a significantly higher risk of developing depressive disorder (adjusted incidence rate ratio [aIRR] = 2.11, p < 0.001), anxiety disorder (aIRR = 2.20, p < 0.001), and sleep disorder (aIRR = 1.76, p = 0.012) when compared with the non-pSS cohort. The risks of developing depressive, anxiety, and sleep disorders were also significantly increased when compared to the rheumatoid arthritis comparison cohort. When the analyses were stratified by sex, depressive disorder (aIRR = 2.10, p < 0.001), anxiety disorder (aIRR = 2.02, p = 0.001), and sleep disorder (aIRR = 1.74, p = 0.022) were found to be significantly increased in female patients with pSS. However, only anxiety disorder (aIRR = 4.88, p = 0.044) was also significantly increased in male patients with pSS. The peak age group of developing depressive disorder was 65–80 years old (aIRR = 3.46, p < 0.001).

Conclusions

In this retrospective cohort study based on population-based claim data, significantly increased incidences of depressive disorder, anxiety disorder, and sleep disorder were observed in patients with pSS.

Key Points
• Patients, particularly women, with primary Sjögren’s syndrome exhibited a significantly higher risk of developing depressive disorder, anxiety disorder, and sleep disorder.
• The peak age group of developing depressive disorder was 65–80 years old.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Fox RI (2005) Sjögren’s syndrome. Lancet 366(9482):321–331

    CAS  Article  Google Scholar 

  2. 2.

    Bowman SJ (2018) Primary Sjögren’s syndrome. Lupus 27(1_suppl):32–35

    CAS  Article  Google Scholar 

  3. 3.

    Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sjögren's syndrome in Taiwan: a population-based study. J Rheumatol 38(4):706–708

    Article  Google Scholar 

  4. 4.

    Kang JH, Lin HC (2010) Comorbidities in patients with primary Sjögren’s syndrome: a registry-based case-control study. J Rheumatol 37(6):1188–1194

    Article  Google Scholar 

  5. 5.

    Cui Y, Li L, Yin R, Zhao Q, Chen S, Zhang Q, Shen B (2018) Depression in primary Sjögren’s syndrome: a systematic review and meta-analysis. Psychol Health Med 23(2):198–209

    Article  Google Scholar 

  6. 6.

    Wan KH, Chen LJ, Young AL (2016) Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond) 30(12):1558–1567

    CAS  Article  Google Scholar 

  7. 7.

    Tishler M, Barak Y, Paran D, Yaron M (1997) Sleep disturbances, fibromyalgia and primary Sjögren’s syndrome. Clin Exp Rheumatol 15(1):71–74

    CAS  PubMed  Google Scholar 

  8. 8.

    Wang LY, Chiang JH, Chen SF, Shen YC (2018) Systemic autoimmune diseases are associated with an increased risk of bipolar disorder: a nationwide population-based cohort study. J Affect Disord 227:31–37

    Article  Google Scholar 

  9. 9.

    Lin CE (2016) One patient with Sjögren’s syndrome presenting schizophrenia-like symptoms. Neuropsychiatr Dis Treat 12:661–663

    Article  Google Scholar 

  10. 10.

    Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163(3):521–528

    Article  Google Scholar 

  11. 11.

    Shen CC, Yang AC, Kuo BI, Tsai SJ (2015) Risk of psychiatric disorders following primary Sjögren syndrome: a nationwide population-based retrospective cohort study. J Rheumatol 42(7):1203–1208

    Article  Google Scholar 

  12. 12.

    National Health Insurance Administration. Ministry of Health and Welfare, Taiwan. Handbook of Taiwan’s National Health Insurance. 2018–2019. https://ws.nhi.gov.tw/001/Upload/293/RelFile/Ebook/English.pdf. Accessed 20 May 2019

  13. 13.

    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S et al (1993) Preliminary classification criteria for Sjögren’s syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 36(3):340–347

    CAS  Article  Google Scholar 

  14. 14.

    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558

    CAS  Article  Google Scholar 

  15. 15.

    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324

    CAS  Article  Google Scholar 

  16. 16.

    Shen CC, Hu LY, Yang AC, Kuo BI, Chiang YY, Tsai SJ (2016) Risk of psychiatric disorders following ankylosing spondylitis: a nationwide population-based retrospective cohort study. J Rheumatol 43(3):625–631

    Article  Google Scholar 

  17. 17.

    Lass P, Krajka-Lauer J, Homziuk M, Iwaszkiewicz-Bilikiewicz B, Koseda M, Hebanowski M, Lyczak P (2000) Cerebral blood flow in Sjögren’s syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21(1):31–35

    CAS  Article  Google Scholar 

  18. 18.

    Pertovaara M, Silvennoinen O, Isomäki P (2016) Cytokine-induced STAT1 activation is increased in patients with primary Sjögren’s syndrome. Clin Immunol 165:60–67

    CAS  Article  Google Scholar 

  19. 19.

    Grygiel-Górniak B, Limphaibool N, Puszczewicz M (2019) Cytokine secretion and the risk of depression development in patients with connective tissue diseases. Psychiatry Clin Neurosci 73(6):302–316

    Article  Google Scholar 

  20. 20.

    Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, Baldwin DS (2017) Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun 62:212–218

    CAS  Article  Google Scholar 

  21. 21.

    de Oliveira FR, Fantucci MZ, Adriano L, Valim V, Cunha TM, Louzada-Junior P, Rocha EM (2018) Neurological and inflammatory manifestations in Sjögren’s syndrome: the role of the kynurenine metabolic pathway. Int J Mol Sci 19(12):3953

    Article  Google Scholar 

  22. 22.

    Hackett KL, Gotts ZM, Ellis J, Deary V, Rapley T, Ng WF, Newton JL, Deane KH (2016) An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature. Rheumatology (Oxford) 56(4):570–580

    Google Scholar 

  23. 23.

    Milin M, Cornec D, Chastaing M, Griner V, Berrouiguet S, Nowak E, Marhadour T, Saraux A, Devauchelle-Pensec V (2016) Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjogren’s syndrome. Joint Bone Spine 83(6):681–685

    Article  Google Scholar 

  24. 24.

    Kuehner C (2017) Why is depression more common among women than among men? Lancet Psychiatry 4(2):146–158

    Article  Google Scholar 

  25. 25.

    Li SH, Graham BM (2017) Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry 4(1):73–82

    Article  Google Scholar 

  26. 26.

    Michael T, Zetsche U, Margraf J (2007) Epidemiology of anxiety disorders. Psychiatry 6(4):136–142

    Article  Google Scholar 

  27. 27.

    Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119–138

    Article  Google Scholar 

  28. 28.

    Seror R Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C, EULAR Sjögren’s Task Force (2010) EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis 69(6):1103–1109

    Article  Google Scholar 

  29. 29.

    Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E et al (2011) EULAR Sjogren’s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome. Ann Rheum Dis 70(6):968–972

    Article  Google Scholar 

Download references

Acknowledgments

This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by the National Health Research Institutes, Taiwan. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare or the National Health Research Institutes, Taiwan.

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Ming-Chi Lu or Malcolm Koo.

Ethics declarations

The study protocol was reviewed and approved by the Institutional Review Board of the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan (Nos. B10104020 and B10004021).

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hsieh, M., Hsu, C., Lu, M. et al. Increased risks of psychiatric disorders in patients with primary Sjögren’s syndrome—a secondary cohort analysis of nationwide, population-based health claim data. Clin Rheumatol 38, 3195–3203 (2019). https://doi.org/10.1007/s10067-019-04705-z

Download citation

Keywords

  • Anxiety
  • Depression
  • Primary Sjögren’s syndrome
  • Sleep disorder